US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist

10.130
-0.880-7.99%

Close Jul 22 16:00 ET

49.68MMarket Cap-191P/E (TTM)

Atara Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

22.94%-29.61M

28.64%-192.98M

11.38%-50.41M

21.08%-51.35M

17.46%-52.8M

54.54%-38.43M

-22.63%-270.43M

-65.98%-56.88M

-10.31%-65.06M

-3.88%-63.96M

Net income from continuing operations

57.53%-31.75M

-20.95%-276.13M

18.94%-60.45M

17.00%-69.8M

-485.08%-71.11M

15.13%-74.77M

32.88%-228.3M

20.11%-74.57M

0.68%-84.09M

122.04%18.47M

Operating gains losses

----

---50.24M

--0

----

Depreciation and amortization

14.58%1.39M

-14.58%4.83M

-3.98%1.21M

-11.69%1.21M

-16.48%1.2M

-23.70%1.21M

-39.51%5.65M

-49.56%1.26M

-40.91%1.37M

-37.96%1.44M

Other non cash items

-2.76%4.05M

85.40%16.8M

41.12%4.08M

56.60%4.34M

52.51%4.22M

556.62%4.16M

340.76%9.06M

302.93%2.89M

412.38%2.77M

584.90%2.77M

Change In working capital

-160.01%-11.73M

124.96%15.34M

-440.84%-7.28M

178.93%1.97M

102.15%1.09M

245.02%19.55M

-216.89%-61.47M

-94.83%2.14M

-91.84%707K

-1,078.21%-50.83M

-Change in receivables

-104.33%-1.73M

115.58%6.11M

15.08%-33.95M

-11.34%344K

-454.84%-110K

12,423.27%39.82M

-14,961.74%-39.24M

-3,953.96%-39.97M

--388K

-99.68%31K

-Change in inventory

-69.90%-6.38M

-411.98%-8.12M

-96.41%-3.12M

--1.27M

---2.52M

---3.75M

---1.59M

--0

-Change in prepaid assets

----

-464.64%-2.16M

-Change in payables and accrued expense

27.31%-2.26M

-391.55%-6.79M

-303.89%-5.45M

5.83%10.8M

-38.99%-9.03M

23.14%-3.11M

-65.25%2.33M

-30.28%2.67M

600.07%10.2M

-117.70%-6.49M

-Change in other current assets

40.95%-1.62M

-16.18%1.32M

-90.82%515K

122.12%911K

10,420.00%2.63M

-5,472.55%-2.74M

-75.68%1.57M

-12.69%5.61M

-45,855.56%-4.12M

225.00%25K

-Change in other current liabilities

50.56%-2.42M

74.41%-1.43M

267.33%7.77M

-2,632.20%-5.98M

2,816.39%1.66M

-337.33%-4.89M

-645.07%-5.59M

-206.46%-4.65M

-28.70%236K

90.88%-61K

-Change in other working capital

146.12%2.67M

227.93%24.26M

-32.73%26.94M

31.04%-5.2M

119.67%8.3M

37.80%-5.78M

-147.50%-18.96M

-9.81%40.05M

-385.83%-7.55M

-3,063.84%-42.17M

Cash from discontinued investing activities

Operating cash flow

22.94%-29.61M

28.64%-192.98M

11.38%-50.41M

21.08%-51.35M

17.46%-52.8M

54.54%-38.43M

-22.63%-270.43M

-65.98%-56.88M

-10.31%-65.06M

-3.88%-63.96M

Investing cash flow

Cash flow from continuing investing activities

345.00%14.72M

-38.97%123.87M

-80.58%9.94M

18.01%70.45M

55.48%49.48M

-109.98%-6.01M

811.83%202.96M

310.57%51.22M

4,899.75%59.7M

-0.20%31.83M

Net PPE purchase and sale

68.17%-127K

-101.32%-1.2M

-18.92%-44K

-93.94%-256K

-100.53%-499K

84.68%-399K

956.07%90.57M

98.50%-37K

96.58%-132K

4,629.16%93.35M

Net investment purchase and sale

364.69%14.84M

11.28%125.06M

-80.51%9.99M

18.18%70.7M

181.24%49.98M

-108.93%-5.61M

242.24%112.38M

334.49%51.26M

1,084.73%59.83M

-281.21%-61.52M

Cash from discontinued investing activities

Investing cash flow

345.00%14.72M

-38.97%123.87M

-80.58%9.94M

18.01%70.45M

55.48%49.48M

-109.98%-6.01M

811.83%202.96M

310.57%51.22M

4,899.75%59.7M

-0.20%31.83M

Financing cash flow

Cash flow from continuing financing activities

10,172.77%24.14M

-96.21%2.01M

-95.32%1.51M

2.80%-208K

-59.29%471K

-98.82%235K

-48.93%53.08M

-37.26%32.29M

-100.45%-214K

-52.72%1.16M

Net issuance payments of debt

27.24%-227K

-82.82%-947K

-76.23%-215K

-0.97%-208K

-68.25%-212K

-387.50%-312K

-103.94%-518K

-96.77%-122K

-232.26%-206K

-96.88%-126K

Net common stock issuance

3,708.44%24.37M

-90.24%2.14M

12.44%1.55M

--0

-117.39%-50K

-96.88%640K

-77.82%21.89M

-97.25%1.38M

--0

69.33%-23K

Proceeds from stock option exercised by employees

--0

-51.69%928K

-61.41%181K

--0

-42.93%747K

--0

-71.59%1.92M

-70.17%469K

-94.42%47K

-49.63%1.31M

Net other financing activities

93.55%-6K

-100.36%-107K

--0

-366.67%-14K

87.08%-93K

2,462.41%29.79M

--30.57M

---55K

76.92%-3K

Cash from discontinued financing activities

Financing cash flow

10,172.77%24.14M

-96.21%2.01M

-95.32%1.51M

2.80%-208K

-59.29%471K

-98.82%235K

-48.93%53.08M

-37.26%32.29M

-100.45%-214K

-52.72%1.16M

Net cash flow

Beginning cash position

-72.08%25.99M

-13.39%93.09M

-2.29%64.94M

-36.08%46.04M

-52.54%48.89M

-13.39%93.09M

-46.74%107.48M

-42.01%66.46M

-42.49%72.03M

-32.45%103.02M

Current changes in cash

120.92%9.25M

-366.30%-67.1M

-246.27%-38.95M

438.95%18.89M

90.82%-2.84M

-890.39%-44.2M

84.74%-14.39M

473.73%26.63M

47.65%-5.57M

-13.73%-30.98M

End cash Position

-27.93%35.23M

-72.08%25.99M

-2.29%64.94M

-36.08%46.04M

-52.54%48.89M

-13.39%93.09M

-42.01%66.46M

-42.49%72.03M

Free cash flow

23.41%-29.74M

29.28%-194.2M

11.36%-50.45M

20.80%-51.63M

18.49%-53.3M

55.44%-38.83M

-18.83%-274.62M

-54.94%-56.92M

-3.75%-65.19M

-2.74%-65.38M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	22.94%-29.61M	28.64%-192.98M	11.38%-50.41M	21.08%-51.35M	17.46%-52.8M	54.54%-38.43M	-22.63%-270.43M	-65.98%-56.88M	-10.31%-65.06M	-3.88%-63.96M
Net income from continuing operations	57.53%-31.75M	-20.95%-276.13M	18.94%-60.45M	17.00%-69.8M	-485.08%-71.11M	15.13%-74.77M	32.88%-228.3M	20.11%-74.57M	0.68%-84.09M	122.04%18.47M
Operating gains losses	----	----	----	----	----	----	---50.24M	--0	--0	----
Depreciation and amortization	14.58%1.39M	-14.58%4.83M	-3.98%1.21M	-11.69%1.21M	-16.48%1.2M	-23.70%1.21M	-39.51%5.65M	-49.56%1.26M	-40.91%1.37M	-37.96%1.44M
Other non cash items	-2.76%4.05M	85.40%16.8M	41.12%4.08M	56.60%4.34M	52.51%4.22M	556.62%4.16M	340.76%9.06M	302.93%2.89M	412.38%2.77M	584.90%2.77M
Change In working capital	-160.01%-11.73M	124.96%15.34M	-440.84%-7.28M	178.93%1.97M	102.15%1.09M	245.02%19.55M	-216.89%-61.47M	-94.83%2.14M	-91.84%707K	-1,078.21%-50.83M
-Change in receivables	-104.33%-1.73M	115.58%6.11M	15.08%-33.95M	-11.34%344K	-454.84%-110K	12,423.27%39.82M	-14,961.74%-39.24M	-3,953.96%-39.97M	--388K	-99.68%31K
-Change in inventory	-69.90%-6.38M	-411.98%-8.12M	-96.41%-3.12M	--1.27M	---2.52M	---3.75M	---1.59M	---1.59M	--0	--0
-Change in prepaid assets	----	----	----	----	----	----	----	----	----	-464.64%-2.16M
-Change in payables and accrued expense	27.31%-2.26M	-391.55%-6.79M	-303.89%-5.45M	5.83%10.8M	-38.99%-9.03M	23.14%-3.11M	-65.25%2.33M	-30.28%2.67M	600.07%10.2M	-117.70%-6.49M
-Change in other current assets	40.95%-1.62M	-16.18%1.32M	-90.82%515K	122.12%911K	10,420.00%2.63M	-5,472.55%-2.74M	-75.68%1.57M	-12.69%5.61M	-45,855.56%-4.12M	225.00%25K
-Change in other current liabilities	50.56%-2.42M	74.41%-1.43M	267.33%7.77M	-2,632.20%-5.98M	2,816.39%1.66M	-337.33%-4.89M	-645.07%-5.59M	-206.46%-4.65M	-28.70%236K	90.88%-61K
-Change in other working capital	146.12%2.67M	227.93%24.26M	-32.73%26.94M	31.04%-5.2M	119.67%8.3M	37.80%-5.78M	-147.50%-18.96M	-9.81%40.05M	-385.83%-7.55M	-3,063.84%-42.17M
Cash from discontinued investing activities
Operating cash flow	22.94%-29.61M	28.64%-192.98M	11.38%-50.41M	21.08%-51.35M	17.46%-52.8M	54.54%-38.43M	-22.63%-270.43M	-65.98%-56.88M	-10.31%-65.06M	-3.88%-63.96M
Investing cash flow
Cash flow from continuing investing activities	345.00%14.72M	-38.97%123.87M	-80.58%9.94M	18.01%70.45M	55.48%49.48M	-109.98%-6.01M	811.83%202.96M	310.57%51.22M	4,899.75%59.7M	-0.20%31.83M
Net PPE purchase and sale	68.17%-127K	-101.32%-1.2M	-18.92%-44K	-93.94%-256K	-100.53%-499K	84.68%-399K	956.07%90.57M	98.50%-37K	96.58%-132K	4,629.16%93.35M
Net investment purchase and sale	364.69%14.84M	11.28%125.06M	-80.51%9.99M	18.18%70.7M	181.24%49.98M	-108.93%-5.61M	242.24%112.38M	334.49%51.26M	1,084.73%59.83M	-281.21%-61.52M
Cash from discontinued investing activities
Investing cash flow	345.00%14.72M	-38.97%123.87M	-80.58%9.94M	18.01%70.45M	55.48%49.48M	-109.98%-6.01M	811.83%202.96M	310.57%51.22M	4,899.75%59.7M	-0.20%31.83M
Financing cash flow
Cash flow from continuing financing activities	10,172.77%24.14M	-96.21%2.01M	-95.32%1.51M	2.80%-208K	-59.29%471K	-98.82%235K	-48.93%53.08M	-37.26%32.29M	-100.45%-214K	-52.72%1.16M
Net issuance payments of debt	27.24%-227K	-82.82%-947K	-76.23%-215K	-0.97%-208K	-68.25%-212K	-387.50%-312K	-103.94%-518K	-96.77%-122K	-232.26%-206K	-96.88%-126K
Net common stock issuance	3,708.44%24.37M	-90.24%2.14M	12.44%1.55M	--0	-117.39%-50K	-96.88%640K	-77.82%21.89M	-97.25%1.38M	--0	69.33%-23K
Proceeds from stock option exercised by employees	--0	-51.69%928K	-61.41%181K	--0	-42.93%747K	--0	-71.59%1.92M	-70.17%469K	-94.42%47K	-49.63%1.31M
Net other financing activities	93.55%-6K	-100.36%-107K	--0	--0	-366.67%-14K	87.08%-93K	2,462.41%29.79M	--30.57M	---55K	76.92%-3K
Cash from discontinued financing activities
Financing cash flow	10,172.77%24.14M	-96.21%2.01M	-95.32%1.51M	2.80%-208K	-59.29%471K	-98.82%235K	-48.93%53.08M	-37.26%32.29M	-100.45%-214K	-52.72%1.16M
Net cash flow
Beginning cash position	-72.08%25.99M	-13.39%93.09M	-2.29%64.94M	-36.08%46.04M	-52.54%48.89M	-13.39%93.09M	-46.74%107.48M	-42.01%66.46M	-42.49%72.03M	-32.45%103.02M
Current changes in cash	120.92%9.25M	-366.30%-67.1M	-246.27%-38.95M	438.95%18.89M	90.82%-2.84M	-890.39%-44.2M	84.74%-14.39M	473.73%26.63M	47.65%-5.57M	-13.73%-30.98M
End cash Position	-27.93%35.23M	-72.08%25.99M	-72.08%25.99M	-2.29%64.94M	-36.08%46.04M	-52.54%48.89M	-13.39%93.09M	-13.39%93.09M	-42.01%66.46M	-42.49%72.03M
Free cash flow	23.41%-29.74M	29.28%-194.2M	11.36%-50.45M	20.80%-51.63M	18.49%-53.3M	55.44%-38.83M	-18.83%-274.62M	-54.94%-56.92M	-3.75%-65.19M	-2.74%-65.38M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall